William J. Farley
About
In The Last Decade
William J. Farley
53 papers receiving 4.7k citations
Hit Papers
Peers
Comparison fields: 5 of 101
- Public Health, Environmental and Occupational Health 3.9k
- Radiology, Nuclear Medicine and Imaging 1.9k
- Ophthalmology 1.3k
- Dermatology 878
- Immunology and Allergy 748
Countries citing papers authored by William J. Farley
This map shows the geographic impact of William J. Farley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William J. Farley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William J. Farley more than expected).
Fields of papers citing papers by William J. Farley
This network shows the impact of papers produced by William J. Farley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William J. Farley. The network helps show where William J. Farley may publish in the future.
Co-authorship network of co-authors of William J. Farley
This figure shows the co-authorship network connecting the top 25 collaborators of William J. Farley. A scholar is included among the top collaborators of William J. Farley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William J. Farley. William J. Farley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 18 | |
| 2 | 30 | |
| 3 | 97 | |
| 4 | 92 | |
| 5 | 343 | |
| 6 | Topical Cyclosporine Emulsion Modulates Immune Response in Experimental Dry Eye | 3 |
| 7 | Tear MMP-9 Activity in Dysfunctional Tear Syndrome | 1 |
| 8 | 53 | |
| 9 | 43 | |
| 10 | 74 | |
| 11 | IFN– Promotes Goblet Cell Loss in Response to Desiccating Ocular Stress | 8 |
| 12 | 360 | |
| 13 | 46 | |
| 14 | Anti–Inflammatory Therapy Preserves Corneal Barrier Function in Experimental Murine Dry Eye | 3 |
| 15 | 266 | |
| 16 | 45 | |
| 17 | 139 | |
| 18 | Experimental Dry Eye Induced Expression of Inflammatory Cytokines ( IL-1ß and TNF- ), MMP-9 and Activated MAPK by the Corneal Epithelium | 6 |
| 19 | Matrix Metalloproteinase-9 (MMP-9) Knockout Alters the Ocular Surface Response to Experimental Dryness | 4 |
| 20 | 167 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.